Benzolamide (CL11366) is a potent carbonic anhydrase ( CA ) inhibitor, with K i s of 15 nM, 9 nM, 94 nM and 78 nM for hCA I , hCA II , EcoCAγ and VchCAγ , respectively. Benzolamide also inhibits CAS3 , with a K i of 54 nM. Benzolamide can be used for the research of glaucoma and seizures.
Products | Products > Disease Areas > Cancer | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Neurological Disease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Carbonic Anhydrase
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.